KLRK1 and cancer: The usage of metalloproteinase inhibitors in combination with chemotherapy can determine the stabilization of NKG2D ligands on the cell surface of drug-induced senescent cancer cells, rendering them more susceptible to NK cell recognition and lysis (35) (Figures 1B,C).